Approximately 40% of participants did not seroconvert or achieve a conservative neutralization threshold post-vaccination.

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...

Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you know for sure? Here are the ...

BARS-13 is under clinical development by Beijing Advaccine Biotechnology and currently in Phase II for Respiratory Syncytial Virus (RSV) Infections.

Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs. According to the ...

Covering coughs and sneezes and washing your hands can help prevent infections, according to the New York City health ...

Virginia is experiencing a high number of hospitalizations for respiratory illnesses, according to data from the Virginia ...

Respiratory syncytial virus (RSV) is on the rise in Indiana, according to the Centers for Disease Control and Prevention.

More Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against respiratory ...

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

Meanwhile, in its latest variant proportion projections today, the CDC reported a further rise in XEC viruses, which are now ...